$IBB News The trouble with fundamentals 1:38 p
Post# of 89337
Posted On: 11/16/2014 11:04:32 AM
$IBB News
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 10:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 10:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 5:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 10:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 2:34 p.m. July 28, 2014 - blogs.marketwatch.com
Future Tech: Berkeley Biolabs CEO on Biotech Investments Not to Miss 7:00 a.m. Nov. 15, 2014 - TheStreet.com
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold? 5:00 a.m. Nov. 15, 2014 - TheStreet.com
Neothetics on deck for IPO 1:46 p.m. Nov. 14, 2014 - Seeking Alpha
S1 Biopharma set for IPO 1:20 p.m. Nov. 14, 2014 - Seeking Alpha
1 Biotech Beast Worth Tracking 11:08 a.m. Nov. 12, 2014 - benzinga.com
PRA Health Sciences on deck for IPO 2:06 p.m. Nov. 11, 2014 - Seeking Alpha
NeuroDerm on deck for IPO 1:38 p.m. Nov. 11, 2014 - Seeking Alpha
Biotech Ripe for Correction as Risk of Cyclical Drawdown Looms 3:15 p.m. Nov. 10, 2014 - TheStreet.com
FibroGen on deck for IPO 1:46 p.m. Nov. 10, 2014 - Seeking Alpha
Stocks Inch to New Records, But Who the Heck Is Buying? 11:25 a.m. Nov. 10, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Market Due for a Pullback, but How Deep? 8:31 p.m. Nov. 9, 2014 - InvestorPlace.com
Jaguar Animal Health postpones IPO 11:57 a.m. Nov. 7, 2014 - Seeking Alpha
Joint Corporation on deck for IPO 11:46 a.m. Nov. 7, 2014 - Seeking Alpha
Nevro debuts strongly 11:03 a.m. Nov. 7, 2014 - Seeking Alpha
Coherus Bio stumbles in debut 1:59 p.m. Nov. 6, 2014 - Seeking Alpha
Post-Election Action Puts Near-Term Trend in Doubt 8:27 p.m. Nov. 5, 2014 - InvestorPlace.com
INC Research on deck for IPO 1:42 p.m. Nov. 5, 2014 - Seeking Alpha
Xenon Pharma up modestly in debut 1:12 p.m. Nov. 5, 2014 - Seeking Alpha
Vote Cannabis? Marijuana Gains Political Traction on the Ballot 5:04 p.m. Nov. 4, 2014 - TheStreet.com
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 10:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 10:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 5:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 10:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 2:34 p.m. July 28, 2014 - blogs.marketwatch.com
Future Tech: Berkeley Biolabs CEO on Biotech Investments Not to Miss 7:00 a.m. Nov. 15, 2014 - TheStreet.com
'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold? 5:00 a.m. Nov. 15, 2014 - TheStreet.com
Neothetics on deck for IPO 1:46 p.m. Nov. 14, 2014 - Seeking Alpha
S1 Biopharma set for IPO 1:20 p.m. Nov. 14, 2014 - Seeking Alpha
1 Biotech Beast Worth Tracking 11:08 a.m. Nov. 12, 2014 - benzinga.com
PRA Health Sciences on deck for IPO 2:06 p.m. Nov. 11, 2014 - Seeking Alpha
NeuroDerm on deck for IPO 1:38 p.m. Nov. 11, 2014 - Seeking Alpha
Biotech Ripe for Correction as Risk of Cyclical Drawdown Looms 3:15 p.m. Nov. 10, 2014 - TheStreet.com
FibroGen on deck for IPO 1:46 p.m. Nov. 10, 2014 - Seeking Alpha
Stocks Inch to New Records, But Who the Heck Is Buying? 11:25 a.m. Nov. 10, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Market Due for a Pullback, but How Deep? 8:31 p.m. Nov. 9, 2014 - InvestorPlace.com
Jaguar Animal Health postpones IPO 11:57 a.m. Nov. 7, 2014 - Seeking Alpha
Joint Corporation on deck for IPO 11:46 a.m. Nov. 7, 2014 - Seeking Alpha
Nevro debuts strongly 11:03 a.m. Nov. 7, 2014 - Seeking Alpha
Coherus Bio stumbles in debut 1:59 p.m. Nov. 6, 2014 - Seeking Alpha
Post-Election Action Puts Near-Term Trend in Doubt 8:27 p.m. Nov. 5, 2014 - InvestorPlace.com
INC Research on deck for IPO 1:42 p.m. Nov. 5, 2014 - Seeking Alpha
Xenon Pharma up modestly in debut 1:12 p.m. Nov. 5, 2014 - Seeking Alpha
Vote Cannabis? Marijuana Gains Political Traction on the Ballot 5:04 p.m. Nov. 4, 2014 - TheStreet.com
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
(0)
(0)